Search results

Order by most recent / most popular / relevance

Results: 1-10 of 325

AOD-9604: patents, peptides, performance and.cellulite?

Phillips Ormonde Fitzpatrick
-
Australia
-
May 14 2013

Australia is no stranger to sporting scandals. Cricket's "John the bookmaker" affair, horse racing's "Fine Cotton" scandal and any number of player

Publisher liability rejected by Philadelphia C.P. Court

Reed Smith LLP
-
USA
-
May 16 2013

Some time ago we were highly critical of a potentially dangerous expansion of liability for failure to warn to publishers of medical literature

Time is running out for FDA's online and social media advertising guidance

Reed Smith LLP
-
USA
-
May 23 2013

Thomas Abrams, director of the Food and Drug Administration (FDA) Office of Prescription Drug Promotion, recently indicated that long-awaited draft

FDA knows time is running out on internet and social media guidance

Reed Smith LLP
-
USA
-
April 29 2013

In a recent interview published by Pharmalot, the Director of the FDA Office of Prescription Drug Promotion (OPDP), Thomas Abrams, indicated that the

Decree on advertising medical devices in France

Hodgson Russ LLP
-
France
-
August 27 2012

A new French law wants to strengthen the safety of drugs and medical products

Navigating FDA guidance on Facebook and social media

Fish & Richardson PC
-
USA
-
March 18 2013

The FDA recently warned AMARC Enterprises, Inc., a California-based dietary supplement company, that its Facebook page was not in compliance with FDA

Could FDA be the next NFL commissioner? What happens when a medical device becomes part of the required uniform

Squire Sanders
-
USA
-
April 10 2013

Recently, the New York Times reported on a decision by the National Football League (NFL) to expand league-wide a 2012 pilot program involving the

Court confirms that a press release to journalists amounts to prohibited advertising of pharmaceuticals

Bird & Bird
-
Sweden
-
May 22 2013

This article is a follow-up to an article in our March 2012 update concerning the decision of the Swedish Medical Products Agency (the "MPA"

Is the writing on the screen? The Ninth Circuit clarifies movie theater captioning obligations

Proskauer Rose LLP
-
USA
-
May 26 2010

In State of Arizona ex rel. Goddard v. Harkins Amusement Enterprises, Inc., No. 08-16075, 2010 U.S. App. LEXIS 9042 (9th Cir. Apr. 30, 2010), the United States Court of Appeals for the Ninth Circuit recently held that while open captioning is not a required auxiliary aid or service in movie theaters as a matter of law under the Americans with Disabilities Act (“ADA”), other forms of closed captioning and descriptive narration (e.g., rear-projection captioning) may be a required auxiliary aid and service, absent a showing by the movie theater of undue burden or a fundamental alteration of its services

ASA adjudications snapshot - March 2012

CMS Cameron McKenna
-
United Kingdom
-
April 30 2012

This case confirms the approach in Eeles v Cobham Hire Services Ltd 2009 remains the court’s position when considering the appropriate level for interim payments of damages

next >

Search results

AOD-9604: patents, peptides, performance and.cellulite?

Publisher liability rejected by Philadelphia C.P. Court

Time is running out for FDA's online and social media advertising guidance

FDA knows time is running out on internet and social media guidance

Decree on advertising medical devices in France

Navigating FDA guidance on Facebook and social media

Could FDA be the next NFL commissioner? What happens when a medical device becomes part of the required uniform

Court confirms that a press release to journalists amounts to prohibited advertising of pharmaceuticals

Is the writing on the screen? The Ninth Circuit clarifies movie theater captioning obligations

ASA adjudications snapshot - March 2012

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea